Age-dependent changes of serum soluble CD30 concentration in children

Pediatric Transplantation

Volumn 15, Issue 5, 2011, Pages 515-518

  Chrul, Slawomir ^a   Polakowska, Ewa ^b  

^a USK 1 ^*  (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

children; ELISA; sCD30; serum

Indexed keywords

CD30 LIGAND; SOLUBLE CD30 LIGAND; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HUMAN; HUMAN EXPERIMENT; INFANT; MALE; NORMAL HUMAN; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADOLESCENT; AGE FACTORS; ANTIGENS, CD30; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; HODGKIN DISEASE; HUMANS; INFANT; INFLAMMATION; LINEAR MODELS; MALE; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 79960612600     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2011.01516.x     Document Type: Article

References (20)

1. Horie R, Watanabe T,. CD30: Expression and function in health and disease. Semin Immunol 1998: 10: 457-470. (Pubitemid 28564375)
2. Del PG, De CM, Almerigogna F, et al., Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J 1995: 9: 81-86.
3. Kennedy MK, Willis CR, Armitage RJ,. Deciphering CD30 ligand biology and its role in humoral immunity. Immunology 2006: 118: 143-152. (Pubitemid 43727419)
4. Leonard C, Tormey V, Faul J, Burke CM, Poulter LW,. Allergen-induced CD30 expression on T cells of atopic asthmatics. Clin Exp Allergy 1997: 27: 780-786. (Pubitemid 27306157)
5. Oflazoglu E, Simpson EL, Takiguchi R, Grewal IS, Hanifin JM, Gerber HP,. CD30 expression on CD1a+ and CD8+ cells in atopic dermatitis and correlation with disease severity. Eur J Dermatol 2008: 18: 41-49. (Pubitemid 351158171)
6. Chilosi M, Facchetti F, Notarangelo LD, et al., CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: Evidence for a T helper 2-mediated condition. Eur J Immunol 1996: 26: 329-334. (Pubitemid 26060237)
7. Seah GT, Rook GA,. High levels of mRNA encoding IL-4 in unstimulated peripheral blood mononuclear cells from tuberculosis patients revealed by quantitative nested reverse transcriptase-polymerase chain reaction; correlations with serum IgE levels. Scand J Infect Dis 2001: 33: 106-109. (Pubitemid 32177993)
8. Wang G, Hansen H, Tatsis E, Csernok E, Lemke H, Gross WL,. High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis. Am J Med 1997: 102: 517-523. (Pubitemid 27305113)
9. Gerli R, Pitzalis C, Bistoni O, et al., CD30+ T cells in rheumatoid synovitis: Mechanisms of recruitment and functional role. J Immunol 2000: 164: 4399-4407. (Pubitemid 30215104)
10. Ihn H, Yazawa N, Kubo M, et al., Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease. J Rheumatol 2000: 27: 698-702. (Pubitemid 30151349)
11. Mcmillan SA, Mcdonnell GV, Douglas JP, Hawkins SA,. Evaluation of the clinical utility of cerebrospinal fluid (CSF) indices of inflammatory markers in multiple sclerosis. Acta Neurol Scand 2000: 101: 239-243. (Pubitemid 30155150)
12. Pizzolo G, Vinante F, Nadali G, et al., High serum level of soluble CD30 in acute primary HIV-1 infection. Clin Exp Immunol 1997: 108: 251-253. (Pubitemid 27223461)
13. Fattovich G, Vinante F, Giustina G, et al., Serum levels of soluble CD30 in chronic hepatitis B virus infection. Clin Exp Immunol 1996: 103: 105-110. (Pubitemid 26027380)
14. Cinti P, Pretagostini R, Arpino A, et al., Evaluation of pretransplant immunologic status in kidney-transplant recipients by panel reactive antibody and soluble CD30 determinations. Transplantation 2005: 79: 1154-1156. (Pubitemid 40664014)
15. Purdue MP, Lan Q, Martinez-Maza O, et al., A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma. Blood 2009: 114: 2730-2732.
16. Chen JY, Fu LS, Chu JJ, Chen HC, Chi CS,. Plasma soluble CD30 level correlates negatively with age in children. J Microbiol Immunol Infect 2007: 40: 168-172.
17. Di LG, Gangemi S, Merendino RA, et al., Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index. Mediators Inflamm 2003: 12: 123-125. (Pubitemid 36783252)
18. Altermann W, Schlaf G, Rothhoff A, Seliger B,. High variation of individual soluble serum CD30 levels of pre-transplantation patients: sCD30 a feasible marker for prediction of kidney allograft rejection? Nephrol Dial Transplant 2007: 22: 2795-2799. (Pubitemid 350093456)
19. Saini D, Ramachandran S, Nataraju A, et al., Activated effector and memory T cells contribute to circulating sCD30: Potential marker for islet allograft rejection. Am J Transplant 2008: 8: 1798-1808.
20. Vaidya S, Partlow D, Barnes T, Thomas P, Gugliuzza K,. Soluble CD30 concentrations in ESRD patients with and without panel reactive HLA antibodies. Clin Transplant 2006: 20: 461-464. (Pubitemid 43983824)